Drug intelligence / Profile preview

acetylglutamine

Development stage
Unknown
Lead developer
Zhejiang Cheng Yi Pharmaceutical
Modality
Small Molecules
Administration
Intravenous
01

Overview

Acetylglutamine (N-acetyl-L-glutamine) is a stable, acetylated derivative of the amino acid L-glutamine. Developed by Zhejiang Cheng Yi Pharmaceutical, it is approved in China as an intravenous injection for parenteral nutrition. Glutamine is a critical energy substrate for rapidly dividing cells, including enterocytes and immune cells, and plays a vital role in nitrogen transport and protein synthesis. Acetylglutamine serves as a more soluble and stable precursor to glutamine, making it suitable for intravenous administration in clinical settings. It is primarily indicated as a nutritional supplement for patients who are critically ill, post-surgical, or otherwise unable to meet their nutritional needs enterally, supporting intestinal barrier integrity and immune function.

Other names
N-acetyl-L-glutamineN-acetylglutamine乙酰谷酰胺注射液N-Acetyl-L-glutamine injection

Beyond the preview

Go deeper on acetylglutamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetylglutamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call